Mitchell E. Horwitz

7.7k total citations · 2 hit papers
144 papers, 3.8k citations indexed

About

Mitchell E. Horwitz is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Mitchell E. Horwitz has authored 144 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Hematology, 45 papers in Oncology and 37 papers in Genetics. Recurrent topics in Mitchell E. Horwitz's work include Hematopoietic Stem Cell Transplantation (95 papers), Polyomavirus and related diseases (27 papers) and Mesenchymal stem cell research (26 papers). Mitchell E. Horwitz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (95 papers), Polyomavirus and related diseases (27 papers) and Mesenchymal stem cell research (26 papers). Mitchell E. Horwitz collaborates with scholars based in United States, Spain and Netherlands. Mitchell E. Horwitz's co-authors include Keith M. Sullivan, David A. Rizzieri, Nelson J. Chao, Richard T. Maziarz, Harry L. Malech, Gwynn D. Long, Steven M. Holland, Patrick J. Stiff, Cristina Gasparetto and John F. DiPersio and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mitchell E. Horwitz

135 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

2009 579 citations Patrick J. Stiff, Richard T. Maziarz et al. Blood profile →
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

2017 400 citations Brent R. Logan, Steven M. Devine et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Mitchell E. Horwitz

Since Specialization

Citations

This map shows the geographic impact of Mitchell E. Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Horwitz more than expected).

Fields of papers citing papers by Mitchell E. Horwitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell E. Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Horwitz. The network helps show where Mitchell E. Horwitz may publish in the future.

Co-authorship network of co-authors of Mitchell E. Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell E. Horwitz. A scholar is included among the top collaborators of Mitchell E. Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell E. Horwitz. Mitchell E. Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study 2024 ·EClinicalMedicine ·Mary Eapen, Joseph H. Antin, Jakub Tolar, Sally Arai, Mitchell E. Horwitz, (unknown), Eric Leifer, John M. McCarty, Ryotaro Nakamura, Michael A. Pulsipher, Scott D. Rowley, Mary M. Horowitz, H. Joachim Deeg	3
2	Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability 2023 ·Transplantation and Cellular Therapy ·Vincent T. Ho, Thomas R. Klumpp, (unknown), (unknown), Mitchell E. Horwitz, Betty K. Hamilton, Kristin Page, Samantha Jaglowski, (unknown), Charles Martinez, (unknown), Allen Chen, Douglas Rizzo	1
3	Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis 2023 ·JCO Oncology Practice ·S. M. Qasim Hussaini, Yi Ren, Alessandro Racioppi, M. Lew, Lauren Bohannon, (unknown), Yan Li, (unknown), (unknown), (unknown), Taewoong Choi, Richard D. Lopez, Stefanie Sarantopoulos, Cristina Gasparetto, Gwynn D. Long, Mitchell E. Horwitz, Nelson J. Chao, S. Yousuf Zafar, Anthony D. Sung	8
4	Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy 2023 ·Transplantation and Cellular Therapy ·Paul Szabolcs, Roei David Mazor, Dima Yackoubov, Stuart B. Levy, Patrick J. Stiff, Andrew R. Rezvani, Rabi Hanna, John E. Wagner, Amy K. Keating, Caroline A. Lindemans, Nicole Karras, Joseph P. McGuirk, Nelson Hamerschlak, (unknown), Guillermo Sanz, David Valcárcel, Mitchell E. Horwitz	6
5	Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials 2023 ·Clinical Cancer Research ·Eduardo Rodríguez‐Arbolí, Catherine J. Lee, Teresa Caballero‐Velázquez, Carmen Martı́nez, (unknown), (unknown), (unknown), Lucía López‐Corral, (unknown), Lynn Onstad, Mitchell E. Horwitz, Stefanie Sarantopoulos, Stephanie J. Lee, Josè Antonio Pérez-Simón	3
6	Financial toxicity and quality of life in patients undergoing bone marrow transplant evaluation: A single center analysis. 2023 ·Journal of Clinical Oncology ·S. M. Qasim Hussaini, Yi Ren, Alessandro Racioppi, M. Lew, Lauren Bohannon, (unknown), (unknown), (unknown), (unknown), Taewoong Choi, Richard D. Lopez, Stefanie Sarantopoulos, Cristina Gasparetto, Gwynn D. Long, Mitchell E. Horwitz, Nelson J. Chao, S. Yousuf Zafar, Anthony D. Sung	1
7	Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplant with Omidubicel Demonstrates Sustained Clinical Improvement Versus Standard Myeloablative Umbilical Cord Blood Transplantation (UCBT): Final Results of a Phase III Randomized, Multicenter Study 2022 ·Transplantation and Cellular Therapy ·Mitchell E. Horwitz, Patrick J. Stiff, Corey Cutler, Claudio G. Brunstein, Andrew R. Rezvani, Rabi Hanna, William Ying Khee Hwang, Richard T. Maziarz, Joseph P. McGuirk, Nicole Karras, Caroline A. Lindemans, David Valcárcel, Liang Piu Koh, Gary J. Schiller, Jaime Sanz, (unknown), (unknown), Guillermo Sanz	1
8	Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood 2022 ·Transplantation and Cellular Therapy ·Chenyu Lin, Gautam Sajeev, Patrick J. Stiff, Claudio G. Brunstein, Corey Cutler, Guillermo Sanz, Caroline A. Lindemans, Andrew R. Rezvani, Rabi Hanna, Liang Piu Koh, Richard T. Maziarz, William Ying Khee Hwang, Yan Song, Qing Liu, (unknown), (unknown), James Signorovitch, Mitchell E. Horwitz, Anthony D. Sung	3
9	Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation 2021 ·Bone Marrow Transplantation ·Coco de Koning, Weiyang Tao, (unknown), (unknown), Mitchell E. Horwitz, Guillermo Sanz, Madan Jagasia, John E. Wagner, Patrick J. Stiff, Rabi Hanna, Daniela Cilloni, David Valcárcel, Tony Peled, (unknown), (unknown), Aridaman Pandit, Caroline A. Lindemans, Jaap Jan Boelens, Stefan Nierkens	3
10	Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial 2020 ·Blood ·Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen, Brent R. Logan, Joseph H. Antin, Peter Dawson, Steven M. Devine, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, Eric Leifer, John Magenau, Joseph P. McGuirk, Lawrence E. Morris, Andrew R. Rezvani, Richard J. Jones, Claudio G. Brunstein	106
11	Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality 2020 ·PLoS ONE ·(unknown), Sendhilnathan Ramalingam, Mohammad Rauf Chaudhry, Yi Ren, Sin‐Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis F. Diehl, Cristina Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung	4
12	Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy 2019 ·Biology of Blood and Marrow Transplantation ·Jennifer L. Saullo, Yanhong Li, Julia A. Messina, (unknown), Tara Dalton, (unknown), Shelby D. Reed, Rachel Miller, Mitchell E. Horwitz, Barbara D. Alexander, Anthony D. Sung	8
13	Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization 2017 ·Biology of Blood and Marrow Transplantation ·Sarah Anand, Samantha M. Thomas, Terry Hyslop, (unknown), Kelly Corbet, Cristina Gasparetto, Richard D. Lopez, Gwynn D. Long, (unknown), David A. Rizzieri, Keith M. Sullivan, Anthony D. Sung, Stefanie Sarantopoulos, Nelson J. Chao, Mitchell E. Horwitz	27
14	Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma 2016 ·Biology of Blood and Marrow Transplantation ·Dharshan Sivaraj, Michael Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, Mitchell E. Horwitz, Richard D. Lopez, Keith M. Sullivan, David A. Rizzieri, Nelson J. Chao, Cristina Gasparetto	22
15	Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation 2015 ·Current Hematologic Malignancy Reports ·Mitchell E. Horwitz	9
16	Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies 2013 ·Biology of Blood and Marrow Transplantation ·Junya Kanda, Gwynn D. Long, Cristina Gasparetto, Mitchell E. Horwitz, Keith M. Sullivan, John P. Chute, Ashley Morris, Michael Shafique, Zhiguo Li, Nelson J. Chao, David A. Rizzieri	8
17	Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment 2013 ·Bone Marrow Transplantation ·Junya Kanda, Leylagül Kaynar, Yoshinobu Kanda, Vinod K. Prasad, Suhag Parikh, Li Lan, Tong Shen, David A. Rizzieri, G D Long, Keith Sullivan, Cristina Gasparetto, John P. Chute, Arthur Morris, Scott Winkel, James C. McPherson, Joanne Kurtzberg, Nelson J. Chao, Mitchell E. Horwitz	37
18	A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma 2013 ·Cancer Investigation ·(unknown), David A. Rizzieri, Gwynn D. Long, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Mitchell E. Horwitz, Nelson J. Chao, Cristina Gasparetto	18
19	Plerixafor Given “Just In Time” For Peripheral Blood Stem Cell Mobilization Of Patients With Suboptimal Response To G-CSF 2010 ·Biology of Blood and Marrow Transplantation ·Mitchell E. Horwitz, (unknown), G D Long, Cristina Gasparetto, Kristen Sullivan, John P. Chute, David A. Rizzieri, (unknown), Nelson J. Chao	1
20	Pediatric large‐volume leukapheresis: a single institution experience with heparin versus citrate‐based anticoagulant regimens 2004 ·Transfusion ·Charles D. Bolan, Yu Ying Yau, (unknown), Mitchell E. Horwitz, Crystal L. Mackall, A. John Barrett, Harry L. Malech, Nadja N. Rehak, Alan S. Wayne, Susan F. Leitman	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact